Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
type: MedicalStudy
description: Randomized Phase II 2 x 2 Factorial Trial of the Addition of Carboplatin +/- Bevacizumab to Neoadjuvant Weekly Paclitaxel Followed by Dose-Dense AC in Hormone Receptor-Poor/HER2-Negative Resectable Breast Cancer
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE2
start date: 2009-07-21
end date: 2025-09-02
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00861705
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: National Cancer Institute (NCI)
study subject: Male Breast Carcinoma
study subject: Stage IIA Breast Cancer AJCC v6 and v7
study subject: Stage IIB Breast Cancer AJCC v6 and v7
study subject: Stage IIIA Breast Cancer AJCC v7
study subject: Triple-Negative Breast Carcinoma
keywords: PHASE2
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Male Breast Carcinoma
keywords: Stage IIA Breast Cancer AJCC v6 and v7
keywords: Stage IIB Breast Cancer AJCC v6 and v7
keywords: Stage IIIA Breast Cancer AJCC v7
keywords: Triple-Negative Breast Carcinoma

AI Analytics
type: Organization